AT2-intrinsic Z-AAT expression drives conserved inflammatory and proteotoxic stress responses and predisposes to emphysema

This study demonstrates that AT2-intrinsic expression of misfolded Z-AAT protein drives conserved proteotoxic and inflammatory stress responses, leading to aberrant cell fate adoption and increased susceptibility to emphysema, thereby establishing a cell-autonomous mechanism contributing to Alpha-1 antitrypsin deficiency pathogenesis beyond the traditional protease-antiprotease imbalance.

The Gist

The Big Picture: A "Double Trouble" Problem

Imagine your lungs are a bustling city. To keep the city safe, there are security guards (proteins) that stop the "construction crews" (enzymes) from accidentally tearing down buildings (lung tissue).

In a condition called Alpha-1 Antitrypsin Deficiency (AATD), the city has a problem. The workers are supposed to make a specific security guard called Alpha-1 Antitrypsin (AAT). But in people with the "Z" mutation, the factory makes a defective, misshapen guard.

For decades, scientists thought the only problem was that not enough good guards were getting to the lungs. They thought the city was just "understaffed," so the construction crews ran wild and destroyed the lung buildings (causing emphysema).

This paper says: "Wait a minute. It's not just about being understaffed. The defective guards are also causing trouble inside the factory."

The New Discovery: The "Clogged Factory"

The researchers discovered that the defective "Z" guards don't just disappear; they get stuck inside the cells that make them (specifically, the Type 2 Alveolar cells, or AT2s, which are the lung's repair crew).

Think of the AT2 cell as a kitchen where the security guards are cooked.

• Normal Kitchen (MM): The chefs cook the guards, package them perfectly, and ship them out to the city.
• Broken Kitchen (ZZ): The chefs try to cook the guards, but the ingredients are wrong. The guards get stuck in the kitchen, forming a cluttered pile of trash (protein aggregates) on the counter.

This paper proves that this "cluttered kitchen" is toxic. It doesn't just mean the city is understaffed; the trash pile inside the kitchen actually:

1. Stresses the chef (causing "proteotoxic stress").
2. Sets off the fire alarm (triggering inflammation).
3. Confuses the chef, making them forget how to cook and start acting like a different type of worker entirely (changing cell fate).

How They Figured It Out (The Three-Pronged Approach)

The researchers didn't just guess; they tested this idea in three different "simulations" to make sure it was real.

1. The "Virtual Kitchen" (iPSCs)

They took skin cells from patients, turned them into stem cells, and then programmed them to become lung cells in a petri dish.

• The Result: They saw that the "ZZ" cells were indeed clogged with the defective guards. These cells were screaming in distress (inflammation) and trying to change their identity, turning into a weird, damaged state they call an "Alveolar Basal Intermediate" (ABI). It's like a chef who, overwhelmed by the mess, starts trying to be a janitor instead.

2. The "Robot Mouse" (Mouse Model)

They created a special mouse where they could turn on the human "Z" gene only in the lung cells.

• The Result: Even though these mice still had their own normal mouse security guards (so the city wasn't understaffed), the lungs with the human "Z" trash pile were much more fragile. When they exposed the mice to a chemical that damages lungs (elastase), the "ZZ" mice got emphysema much faster than the others.
• The Takeaway: The trash pile itself makes the lung weak, even if you have enough security guards.

3. The "Real World Check" (Human Data)

They looked at actual lung tissue from human patients with severe lung disease.

• The Result: The human cells showed the exact same "screaming" patterns (inflammation and stress genes) that they saw in the virtual kitchens and the robot mice.

The "Fire Alarm" Analogy

The paper highlights a specific pathway called NF-κB.

• Imagine the cell is a house. The defective "Z" protein is like a pile of wet, smoldering leaves in the living room.
• The cell's natural reaction is to turn on the Fire Alarm (Inflammation/NF-κB).
• In a healthy house, the alarm goes off once, the fire is put out, and everything is fine.
• In the "ZZ" house, the leaves keep piling up, so the alarm is blasting 24/7. This constant noise (chronic inflammation) eventually burns the house down (emphysema).

Why This Matters

This changes how we might treat the disease.

• Old Thinking: "We need to give the patient more security guards (augmentation therapy) to stop the construction crews."
• New Thinking: "We also need to clean up the kitchen." We need to help the cell get rid of the trash pile, stop the fire alarm from blaring, and prevent the chef from panicking and changing into the wrong type of worker.

Summary

This paper proves that in Alpha-1 Antitrypsin Deficiency, the disease isn't just caused by a lack of good protein. It is also caused by the toxic presence of the bad protein inside the lung cells. This "bad protein" acts like a clogged drain that stresses the cell, sets off constant fire alarms (inflammation), and makes the lungs incredibly vulnerable to damage, leading to emphysema.

Technical Summary

1. Problem Statement

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder caused by the SERPINA1 "Z" mutation (G342K), leading to the misfolding and polymerization of the Z-AAT protein within the endoplasmic reticulum (ER).

• Classical Paradigm: Emphysema in AATD patients has traditionally been attributed to a loss-of-function mechanism: a deficiency of circulating AAT reaching the lungs results in unopposed neutrophil elastase activity, destroying lung parenchyma.
• The Gap: Evidence suggests that many patients with AATD experience lung decline despite augmentation therapy (protein replacement), implying a gain-of-function toxicity mechanism. Specifically, the accumulation of misfolded Z-AAT within resident lung cells (Type 2 alveolar epithelial cells, or AT2s) may drive disease.
• Limitation of Existing Models: Previous mouse models either lacked AAT expression entirely or did not express Z-AAT specifically in lung epithelium. Immortalized cell lines fail to recapitulate primary AT2 biology. There was a lack of systems to study the cell-intrinsic consequences of Z-AAT expression in human AT2s.

2. Methodology

The authors employed a multi-modal approach integrating three distinct model systems to isolate the effects of Z-AAT expression specifically within AT2s:

• Human iPSC-Derived AT2s (iAT2s):
  • Generated syngeneic pairs of induced pluripotent stem cells (iPSCs) from four donors using CRISPR/Cas9 to create isogenic ZZ (mutant) and MM (wild-type) lines.
  • Differentiated these iPSCs into AT2-like cells (iAT2s) using a directed differentiation protocol.
  • Performed single-cell RNA sequencing (scRNA-seq) to analyze transcriptomic heterogeneity.
• Novel Conditional Mouse Model:
  • Developed a transgenic mouse line (Rosa26LSL-SERPINA1-2A-eYFP) crossed with Sftpc-CreERT2.
  • This allows for AT2-specific, inducible expression of either human wild-type (MM) or mutant (ZZ) AAT upon tamoxifen administration.
  • Crucially, these mice retain endogenous murine Serpina1, allowing the study of cell-intrinsic toxicity independent of systemic protease-antiprotease imbalance.
  • Mice were subjected to intratracheal porcine pancreatic elastase (PPE) to induce experimental emphysema.
• Human Clinical Data Validation:
  • Analyzed an independent single-nucleus RNA sequencing (snRNA-seq) dataset from the NHLBI Lung Tissue Research Consortium (LTRC), comparing AT2s from ZZ-COPD patients against MM-COPD patients.
  • Cross-referenced findings with a previously published dataset from the University of Pennsylvania (UPenn).

3. Key Contributions

• Establishment of Syngeneic Models: Created the first isogenic human iPSC-derived AT2 models (ZZ vs. MM) and a novel conditional mouse model expressing human Z-AAT specifically in AT2s.
• Demonstration of Cell-Intrinsic Toxicity: Provided functional evidence that Z-AAT expression within AT2s is sufficient to drive emphysema susceptibility, independent of systemic AAT deficiency.
• Identification of a Conserved Transcriptional Signature: Defined a specific disease signature in Z-AAT expressing AT2s characterized by proteotoxic stress, innate immune activation, and aberrant cell fate adoption.
• Discovery of Heterogeneity: Revealed that Z-AAT retention and stress responses are heterogeneous, affecting only a subset of AT2s, with a specific subpopulation adopting an "Alveolar Basal Intermediate" (ABI) state.

4. Key Results

A. Intracellular Retention and Polymerization

• iAT2s: Flow cytometry and immunostaining confirmed that ZZ-iAT2s exhibit heterogeneous intracellular retention of AAT protein (0–19% of cells), whereas MM-iAT2s show negligible retention.
• Mouse Model: In AT2SERPINA1-ZZ mice, 92% of AT2s expressed human AAT, but only a fraction secreted it into the bronchoalveolar lavage fluid (BALF) compared to MM mice. Importantly, polymer-specific antibodies (2C1) detected Z-AAT polymers in 21% of AT2SERPINA1-ZZ AT2s, confirming intracellular aggregation.

B. Transcriptomic Signatures of Stress

• Heterogeneity in iAT2s: scRNA-seq of ZZ-iAT2s revealed distinct clusters. One specific cluster (Cluster 4) exhibited a "proteotoxic stress" signature characterized by:
  • Upregulation of ER chaperones (e.g., HSPA6, HSPA1B).
  • Activation of the PERK-eIF2α arm of the Unfolded Protein Response (UPR).
  • Expression of inflammatory cytokines (e.g., CXCL8).
  • Adoption of an Alveolar Basal Intermediate (ABI) state, marked by KRT17 and other basaloid markers, emerging cell-autonomously without mesenchymal co-culture.
• Conservation Across Models: A core set of 137 genes was upregulated across all three systems (ZZ-iAT2s, AT2SERPINA1-ZZ mice, and human ZZ-COPD AT2s).
  • Pathways: Enrichment in "TNFα Signaling via NF-κB," "Hypoxia," "Apoptosis," and "Unfolded Protein Response."
  • Key Genes: NFKBIZ, REL, XBP1, SOD2, JUND, and GADD45B.
  • NF-κB Activation: Both human and mouse ZZ-AT2s showed significantly elevated NF-κB module scores, indicating a cell-intrinsic inflammatory drive.

C. Functional Consequences: Emphysema Susceptibility

• In Vivo Injury Model: When AT2SERPINA1-ZZ mice were challenged with elastase (PPE) to induce emphysema, they developed significantly larger mean linear intercepts (MLI) (indicating greater airspace enlargement) compared to AT2SERPINA1-MM and control mice.
• Significance: This occurred despite the mice having intact endogenous murine AAT, proving that the gain-of-function toxicity of Z-AAT within AT2s is sufficient to predispose the lung to injury and emphysema.

5. Significance and Conclusion

This study fundamentally shifts the understanding of AATD-associated emphysema pathogenesis:

1. Beyond Loss-of-Function: It validates that AATD lung disease is not solely caused by a lack of antiprotease protection but is driven by cell-intrinsic gain-of-function toxicity of misfolded Z-AAT within AT2s.
2. Mechanism of Injury: The misfolded protein triggers a conserved stress response involving ER stress (PERK pathway), NF-κB-mediated inflammation, and aberrant cell fate transitions (towards an ABI state).
3. Therapeutic Implications: The findings suggest that therapeutic strategies for AATD should not only focus on replacing circulating AAT but also on targeting the intracellular proteotoxic stress and inflammatory signaling within lung epithelial cells.
4. Model Utility: The novel mouse model and syngeneic iPSC system provide robust platforms for future drug screening aimed at reducing Z-AAT aggregation or mitigating the downstream inflammatory cascade.

In summary, the authors demonstrate that Z-AAT expression in AT2s induces a heterogeneous, cell-autonomous stress response that drives inflammation and impairs lung repair, directly contributing to emphysema pathogenesis.